1 not yet recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Preoperative: new trials by email Literature Review of Preoperative trials Research Report on Preoperative
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Single-Arm, Multicenter, Exploratory Clinical Study of TACE Combined With Iparomlimab and Tuvonralimab Injection (QL1706) and Lenvatinib for Perioperative Treatment of Resectable Hepatocellular Carcinoma Radical surgery, TACE treatment, Iparomlimab and Tuvonralimab Injection (QL1706) - Hepatocellular Carcinoma, Immunotherapy | Phase 2 | Not yet recruiting | The First Affiliated Hospital with Nanjing Medical University | 48 | 2025-08-11 | 2025-08-20 |
Carcinoma, Hepatocellular (1) · Diabetes Mellitus, Insulin-Dependent, 12 (1)
Adenocarcinoma (1) · Carcinoma (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Liver Diseases (1) · Liver Neoplasms (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Glandular and Epithelial (1)
lenvatinib (1)
The First Affiliated Hospital with Nanjing Medical University (1)
China (1)
Xuehao Wang (1) · Yongxiang Xia (1)